what next?, page-3

Two years ago I thought:

the USPTO dispute had been resolved; management had confirmed that the withdrawal of Pfizer was unlikely to delay TT-034 getting to the clinic; the cancer pain, NSCLC and HBV programs had all commenced; the HIV clinical trial was moderately successful and the "Directors have a reasonable expectation that the program can be partnered in 2011";

I knew we were going to need more money but I thought that given the above this was going to be a great time to re-invest in BLT and I should, for once, get to enjoy the benefits of the options that would attach to a share placement.

One year ago I thought:

Management is talking about having three drugs in clinical trials in 2013; the HCV program has been delayed but it is going to be so far ahead of the crowd it is still worthwhile; HIV seems to have fallen by the wayside but the other programs should make up for that; all in all, a little confusing but should still be good.

I posted on HC that we should all be like Rip van Winkle and wake up in 12 months time and all would be sweet.


Now the twelve months is up and I am more confused than ever. None of the above has eventuated yet but let's hope that in the next few weeks we get announcements that turn this ship around and get it back on course.